← Open Payments lookup

GINGER SHUPE: Open Payments

NPI 1689931115 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$27,907 in 135 payments from 12 companies in 2025. Trend: 2023 $902 · 2024 $17,590 · 2025 $27,907

Speaker / faculty: $13,500Consulting: $7,870Food & beverage: $4,488Travel & lodging: $1,938Education: $111
CompanyPaymentsAmount
ABBVIE INC.27$14,117
E.R. Squibb & Sons, L.L.C.29$10,742
Teva Pharmaceuticals USA, Inc.19$924
Neurocrine BioSciences, Inc.19$719
Otsuka America Pharmaceutical, Inc.13$475
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$288
Luye Pharma (USA) Ltd.3$161
Axsome Therapeutics, Inc.1$125
Alkermes, Inc.5$118
Lundbeck LLC5$114

Products named: VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, REXULTI, CAPLYTA, UZEDY, ERZOFRI EXTENDED-RELEASE.

Industry payments across FL — which companies pay providers there.